| scholarly article | Q13442814 |
| P50 | author | Mi Kyung Kim | Q88178605 |
| Soon Hee Lee | Q89083676 | ||
| Dae Young Hur | Q91244545 | ||
| YeongSeok Kim | Q91390149 | ||
| P2093 | author name string | Daejin Kim | |
| Eun Ju Lee | |||
| Byoung Doo Rhee | |||
| Jeong Hyun Park | |||
| Tae Nyun Kim | |||
| Byul-Nim Ahn | |||
| Ga Bin Park | |||
| Jae Wook Yang | |||
| Jung Eun Jang | |||
| Min Jeong Kwon | |||
| P2860 | cites work | Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes | Q22250883 |
| Honokiol causes the p21WAF1-mediated G(1)-phase arrest of the cell cycle through inducing p38 mitogen activated protein kinase in vascular smooth muscle cells | Q24302114 | ||
| PPAR delta: a dagger in the heart of the metabolic syndrome | Q24541527 | ||
| Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review | Q26850912 | ||
| Diabetes and cancer: a consensus report. | Q27686977 | ||
| p53, the cellular gatekeeper for growth and division | Q27860990 | ||
| Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: exploring the hyperinsulinaemia hypothesis | Q28346805 | ||
| Pioglitazone Use and Risk of Bladder Cancer: an In Vitro Study. | Q55356554 | ||
| Glucose-regulated phosphorylation of TET2 by AMPK reveals a pathway linking diabetes to cancer | Q59083181 | ||
| Activation of the peroxisome proliferator-activated receptor γ promotes the development of colon tumors in C57BL/6J-APCMin/+ mice | Q62660251 | ||
| Prevention of hyperglycemia in the Zucker diabetic fatty rat by treatment with metformin or troglitazone | Q71738076 | ||
| Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells | Q74392346 | ||
| Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients | Q80853249 | ||
| Possible link of pioglitazone with bladder cancer in Japanese patients with type 2 diabetes | Q85642529 | ||
| Diabetes mellitus and risk of bladder cancer: a meta-analysis of cohort studies | Q86316589 | ||
| p38 mitogen-activated protein kinase contributes to cell cycle regulation by cAMP in FRTL-5 thyroid cells | Q28581193 | ||
| Fat and beyond: the diverse biology of PPARgamma | Q29615416 | ||
| Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women | Q33544123 | ||
| Cancer risks among patients with type 2 diabetes: a 10-year follow-up study of a nationwide population-based cohort in Taiwan | Q33756122 | ||
| Inhibition of cellular proliferation through IkappaB kinase-independent and peroxisome proliferator-activated receptor gamma-dependent repression of cyclin D1. | Q33967999 | ||
| Metformin and other biguanides in oncology: advancing the research agenda | Q34196114 | ||
| Transcriptional amplification in tumor cells with elevated c-Myc. | Q34302542 | ||
| Peroxisome proliferator-activated receptor-gamma: from adipogenesis to carcinogenesis | Q34313734 | ||
| Risk of bladder cancer in patients with diabetes mellitus: an updated meta-analysis of 36 observational studies | Q34353701 | ||
| Metformin and breast cancer risk: a meta-analysis and critical literature review | Q34357389 | ||
| Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study. | Q34628009 | ||
| Pioglitazone Use and Risk of Bladder Cancer and Other Common Cancers in Persons With Diabetes. | Q34671802 | ||
| Pioglitazone use and risk of bladder cancer: population based cohort study | Q34676639 | ||
| Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer | Q34719830 | ||
| Metformin suppresses ovarian cancer growth and metastasis with enhancement of cisplatin cytotoxicity in vivo. | Q34887704 | ||
| Assessing the association of pioglitazone use and bladder cancer through drug adverse event reporting | Q35043204 | ||
| The MYC oncogene as a cancer drug target | Q35137558 | ||
| Pioglitazone and bladder cancer: a population-based study of Taiwanese. | Q35688201 | ||
| c-myc copy number gains in bladder cancer detected by fluorescence in situ hybridization | Q35795090 | ||
| Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis | Q35842470 | ||
| Free insulin-like growth factors -- measurements and relationships to growth hormone secretion and glucose homeostasis | Q35874079 | ||
| New pharmacological perspectives and therapeutic potential of PPAR-gamma agonists | Q35972388 | ||
| The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study | Q36001145 | ||
| Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study | Q36013549 | ||
| Expression of GLUT1 is associated with increasing grade of malignancy in non-invasive and invasive urothelial carcinomas of the bladder. | Q36121595 | ||
| Pioglitazone and bladder cancer: a propensity score matched cohort study | Q36562522 | ||
| Diabetes mellitus and risk of bladder cancer: a meta-analysis | Q36615062 | ||
| Diabetes Pharmacotherapies and Bladder Cancer: A Medicare Epidemiologic Study | Q36712191 | ||
| Pioglitazone after Ischemic Stroke or Transient Ischemic Attack | Q36953272 | ||
| CDK inhibitors: cell cycle regulators and beyond | Q37081857 | ||
| Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women | Q37090766 | ||
| Comparing pioglitazone to insulin with respect to cancer, cardiovascular and bone fracture endpoints, using propensity score weights | Q37115436 | ||
| Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle | Q37175187 | ||
| Pioglitazone use and risk of bladder cancer in patients with type 2 diabetes: retrospective cohort study using datasets from four European countries | Q37179822 | ||
| PPARgamma2 expression in growth plate chondrocytes is regulated by p38 and GSK-3. | Q37334975 | ||
| Treatment with the oral antidiabetic agent troglitazone improves beta cell responses to glucose in subjects with impaired glucose tolerance | Q37370271 | ||
| The influence of high glucose and high insulin on mechanisms controlling cell cycle progression and arrest in mouse C2C12 myoblasts: the comparison with IGF-I effect. | Q37629208 | ||
| Metformin: taking away the candy for cancer? | Q37775372 | ||
| Thiazolidinedione safety | Q38012205 | ||
| Excess risk of primary liver cancer in patients with diabetes mellitus | Q38506217 | ||
| Metformin sensitizes human bladder cancer cells to TRAIL-induced apoptosis through mTOR/S6K1-mediated downregulation of c-FLIP. | Q39006307 | ||
| Sequential treatment of HPV E6 and E7-expressing TC-1 cells with bortezomib and celecoxib promotes apoptosis through p-p38 MAPK-mediated downregulation of cyclin D1 and CDK2. | Q39015730 | ||
| The antidiabetic drug metformin inhibits the proliferation of bladder cancer cells in vitro and in vivo | Q39042097 | ||
| The antidiabetic drug metformin suppresses HER2 (erbB-2) oncoprotein overexpression via inhibition of the mTOR effector p70S6K1 in human breast carcinoma cells | Q39902046 | ||
| Comparative safety of pioglitazone versus clinically meaningful treatment alternatives concerning the risk of bladder cancer in older US adults with type 2 diabetes | Q40141299 | ||
| Ten-year observational follow-up of PROactive: a randomized cardiovascular outcomes trial evaluating pioglitazone in type 2 diabetes | Q41107308 | ||
| Oxidative Stress in Pancreatic Beta Cell Regeneration. | Q41440755 | ||
| Role of the Rb/E2F pathway in cell growth control | Q41640467 | ||
| Peroxisome proliferator-activated receptor gamma ligands inhibit retinoblastoma phosphorylation and G1--> S transition in vascular smooth muscle cells | Q41734805 | ||
| Basal insulin and cardiovascular and other outcomes in dysglycemia | Q42507791 | ||
| Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in db/db mice | Q42553759 | ||
| PPARgamma controls cell proliferation and apoptosis in an RB-dependent manner | Q42800039 | ||
| Role of PPARgamma in regulating a cascade expression of cyclin-dependent kinase inhibitors, p18(INK4c) and p21(Waf1/Cip1), during adipogenesis | Q42814868 | ||
| Advanced glycation end products downregulates peroxisome proliferator-activated receptor γ expression in cultured rabbit chondrocyte through MAPK pathway | Q42878186 | ||
| Pioglitazone use and the risk of bladder cancer. | Q43526947 | ||
| Fasting serum glucose level and cancer risk in Korean men and women | Q43943327 | ||
| Risk of Pancreatic Cancer Following Diabetes Mellitus: a Nationwide Cohort Study in Sweden | Q44234309 | ||
| Induction of p21 by p53 following DNA damage inhibits both Cdk4 and Cdk2 activities | Q45286138 | ||
| p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. | Q45993768 | ||
| Inhibition of MAP kinase blocks insulin-mediated DNA synthesis and transcriptional activation of c-fos by Elk-1 in vascular smooth muscle cells | Q46646892 | ||
| Activators of the nuclear receptor PPARgamma enhance colon polyp formation | Q46754355 | ||
| Diabetes mellitus, body size and bladder cancer risk in a prospective study of Swedish men. | Q47220430 | ||
| In vivo expression patterns of MyoD, p21, and Rb proteins in myonuclei and satellite cells of denervated rat skeletal muscle | Q47764582 | ||
| 8. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2018. | Q49988613 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | metformin | Q19484 |
| glucose | Q37525 | ||
| P304 | page(s) | 2376512 | |
| P577 | publication date | 2019-01-09 | |
| P1433 | published in | Journal of Diabetes Research | Q26841822 |
| P1476 | title | High Glucose with Insulin Induces Cell Cycle Progression and Activation of Oncogenic Signaling of Bladder Epithelial Cells Cotreated with Metformin and Pioglitazone | |
| P478 | volume | 2019 |
| Q92988876 | Hyperglycemia-Induced Aberrant Cell Proliferation; A Metabolic Challenge Mediated by Protein O-GlcNAc Modification |
| Q97419293 | Metformin inhibits cervical cancer cell proliferation by modulating PI3K/Akt-induced major histocompatibility complex class I-related chain A gene expression |
| Q89907940 | Sera Anti-P53 Antibody Provides New Information Which Explains the Link Between Diabetes and Cancer |
Search more.